• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A next-generation sequencing gene panel (MiamiOtoGenes) for comprehensive analysis of deafness genes.用于耳聋基因综合分析的下一代测序基因检测板(迈阿密耳科基因检测板)
Hear Res. 2016 Mar;333:179-184. doi: 10.1016/j.heares.2016.01.018. Epub 2016 Feb 2.
2
Deafness in the genomics era.基因组学时代的耳聋
Hear Res. 2011 Dec;282(1-2):1-9. doi: 10.1016/j.heares.2011.10.001. Epub 2011 Oct 8.
3
Carrier re-sequencing reveals rare but benign variants in recessive deafness genes.携带体测序揭示隐性耳聋基因中的罕见但良性变体。
Sci Rep. 2017 Sep 12;7(1):11355. doi: 10.1038/s41598-017-10099-2.
4
Development and Validation of a Next-Generation Sequencing Panel for Syndromic and Nonsyndromic Hearing Loss.下一代测序panel 用于综合征型和非综合征型听力损失的研发和验证。
J Appl Lab Med. 2020 May 1;5(3):467-479. doi: 10.1093/jalm/jfaa021.
5
A targeted gene capture next-generation sequencing panel for genetic screening of newborns.一种用于新生儿遗传筛查的靶向基因捕获下一代测序panel。
J Pak Med Assoc. 2020 Oct;70(10):1789-1794. doi: 10.5455/JPMA.28637.
6
Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities.靶向基因捕获和下一代测序技术在人类耳聋和其他遗传障碍研究中的应用。
Hear Res. 2012 Jun;288(1-2):67-76. doi: 10.1016/j.heares.2012.01.004. Epub 2012 Jan 14.
7
Whole-exome sequencing and its impact in hereditary hearing loss.全外显子组测序及其在遗传性听力损失中的影响。
Genet Res (Camb). 2015 Mar 31;97:e4. doi: 10.1017/S001667231500004X.
8
Targeted Next-Generation Sequencing of a Deafness Gene Panel (MiamiOtoGenes) Analysis in Families Unsuitable for Linkage Analysis.针对不适合连锁分析的家族进行耳聋基因panel(MiamiOtoGenes)的靶向下一代测序分析。
Biomed Res Int. 2018 Jan 15;2018:3103986. doi: 10.1155/2018/3103986. eCollection 2018.
9
A low-cost exon capture method suitable for large-scale screening of genetic deafness by the massively-parallel sequencing approach.一种适用于通过大规模平行测序方法对遗传性耳聋进行大规模筛查的低成本外显子捕获方法。
Genet Test Mol Biomarkers. 2012 Jun;16(6):536-42. doi: 10.1089/gtmb.2011.0187. Epub 2012 Apr 5.
10
Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel.采用定制基因检测板的新一代测序技术对主要遗传性肾脏疾病进行综合基因检测方法。
Clin Exp Nephrol. 2017 Feb;21(1):63-75. doi: 10.1007/s10157-016-1252-1. Epub 2016 Feb 26.

引用本文的文献

1
Spectrum of DNA variants for patients with hearing loss in 4 language families of 15 ethnicities from Southwestern China.中国西南地区15个民族4个语系听力损失患者的DNA变异谱
Heliyon. 2024 Oct 2;10(20):e38802. doi: 10.1016/j.heliyon.2024.e38802. eCollection 2024 Oct 30.
2
Hearing loss and vestibular schwannoma: new insights into Schwann cells implication.听力损失与前庭神经鞘瘤:施旺细胞作用的新见解。
Cell Death Dis. 2023 Sep 23;14(9):629. doi: 10.1038/s41419-023-06141-z.
3
Genetic screening of a Chinese cohort of children with hearing loss using a next-generation sequencing panel.采用下一代测序 panel 对中国听障患儿队列进行遗传筛查。
Hum Genomics. 2023 Jan 4;17(1):1. doi: 10.1186/s40246-022-00449-1.
4
Network pharmacology analysis and experimental verification reveal the mechanism of the traditional Chinese medicine YU-Pingfeng San alleviating allergic rhinitis inflammatory responses.网络药理学分析与实验验证揭示了中药玉屏风散减轻变应性鼻炎炎症反应的机制。
Front Plant Sci. 2022 Aug 9;13:934130. doi: 10.3389/fpls.2022.934130. eCollection 2022.
5
NGS-driven molecular diagnosis of heterogeneous hereditary neurological disorders reveals novel and known variants in disease-causing genes.基于 NGS 的异质性遗传性神经疾病的分子诊断揭示了致病基因中的新型和已知变异。
Mol Genet Genomics. 2022 Nov;297(6):1601-1613. doi: 10.1007/s00438-022-01945-8. Epub 2022 Aug 24.
6
Transcriptomic Profile Reveals Deregulation of Hearing-Loss Related Genes in Vestibular Schwannoma Cells Following Electromagnetic Field Exposure.转录组谱揭示了电磁场暴露后前庭神经鞘瘤细胞中与听力损失相关基因的失调。
Cells. 2021 Jul 20;10(7):1840. doi: 10.3390/cells10071840.
7
Spectrum of Mutations in an Indigenous South African Population Further Elucidates the Nonsyndromic Autosomal Recessive Phenotype of DFNB2 to Include Both Homozygous and Compound Heterozygous Mutations.南非土著人群基因突变谱进一步阐明了非综合征常染色体隐性遗传型 DFNB2 的表型,包括纯合子和复合杂合子突变。
Genes (Basel). 2021 Feb 15;12(2):274. doi: 10.3390/genes12020274.
8
Improving the Management of Patients with Hearing Loss by the Implementation of an NGS Panel in Clinical Practice.通过在临床实践中实施 NGS -panel 提高听力损失患者的管理水平。
Genes (Basel). 2020 Dec 7;11(12):1467. doi: 10.3390/genes11121467.
9
Screening Consanguineous Families for Hearing Loss Using the MiamiOtoGenes Panel.使用迈阿密耳基因panel 对近亲家族进行听力损失筛查。
Genet Test Mol Biomarkers. 2020 Oct;24(10):674-680. doi: 10.1089/gtmb.2020.0153. Epub 2020 Sep 29.
10
Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice.现代循环游离 DNA 诊断工具在临床实践中检测特定肿瘤细胞的潜力。
Biochem Med (Zagreb). 2020 Oct 15;30(3):030504. doi: 10.11613/BM.2020.030504. Epub 2020 Aug 5.

本文引用的文献

1
Comprehensive analysis via exome sequencing uncovers genetic etiology in autosomal recessive nonsyndromic deafness in a large multiethnic cohort.通过外显子组测序进行的综合分析揭示了一个大型多民族队列中常染色体隐性非综合征性耳聋的遗传病因。
Genet Med. 2016 Apr;18(4):364-71. doi: 10.1038/gim.2015.89. Epub 2015 Jul 30.
2
Toward Best Practice in Using Molecular Diagnosis to Guide Medical Management, Are We There Yet?在使用分子诊断指导医疗管理方面迈向最佳实践,我们做到了吗?
N Am J Med Sci (Boston). 2014 Oct;7(4):199-200.
3
The Genetic Basis of Nonsyndromic Hearing Loss in Indian and Pakistani Populations.印度和巴基斯坦人群非综合征性听力损失的遗传基础
Genet Test Mol Biomarkers. 2015 Sep;19(9):512-27. doi: 10.1089/gtmb.2015.0023. Epub 2015 Jul 17.
4
Whole-exome sequencing and its impact in hereditary hearing loss.全外显子组测序及其在遗传性听力损失中的影响。
Genet Res (Camb). 2015 Mar 31;97:e4. doi: 10.1017/S001667231500004X.
5
A missense mutation in DCDC2 causes human recessive deafness DFNB66, likely by interfering with sensory hair cell and supporting cell cilia length regulation.DCDC2基因中的一个错义突变导致人类隐性耳聋DFNB66,可能是通过干扰感觉毛细胞和支持细胞的纤毛长度调节来实现的。
Hum Mol Genet. 2015 May 1;24(9):2482-91. doi: 10.1093/hmg/ddv009. Epub 2015 Jan 18.
6
Clinical exome sequencing for genetic identification of rare Mendelian disorders.用于罕见孟德尔疾病基因鉴定的临床外显子组测序
JAMA. 2014 Nov 12;312(18):1880-7. doi: 10.1001/jama.2014.14604.
7
Molecular findings among patients referred for clinical whole-exome sequencing.接受临床全外显子组测序的患者的分子研究结果。
JAMA. 2014 Nov 12;312(18):1870-9. doi: 10.1001/jama.2014.14601.
8
FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing.FAM65B 是毛细胞静纤毛相关的膜蛋白,是听觉所必需的。
Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9864-8. doi: 10.1073/pnas.1401950111. Epub 2014 Jun 23.
9
The promise of whole-exome sequencing in medical genetics.全外显子组测序在医学遗传学中的应用前景。
J Hum Genet. 2014 Jan;59(1):5-15. doi: 10.1038/jhg.2013.114. Epub 2013 Nov 7.
10
Clinical whole-exome sequencing for the diagnosis of mendelian disorders.临床全外显子测序用于孟德尔疾病的诊断。
N Engl J Med. 2013 Oct 17;369(16):1502-11. doi: 10.1056/NEJMoa1306555. Epub 2013 Oct 2.

用于耳聋基因综合分析的下一代测序基因检测板(迈阿密耳科基因检测板)

A next-generation sequencing gene panel (MiamiOtoGenes) for comprehensive analysis of deafness genes.

作者信息

Tekin Demet, Yan Denise, Bademci Guney, Feng Yong, Guo Shengru, Foster Joseph, Blanton Susan, Tekin Mustafa, Liu Xuezhong

机构信息

Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

Dr. John T. Macdonald Foundation Department of Human Genetics, and John P. Hussman Institute for Human Genomics, University of Miami, Miami, FL 33136, USA.

出版信息

Hear Res. 2016 Mar;333:179-184. doi: 10.1016/j.heares.2016.01.018. Epub 2016 Feb 2.

DOI:10.1016/j.heares.2016.01.018
PMID:26850479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4798889/
Abstract

Extreme genetic heterogeneity along with remarkable variation in the distribution of causative variants across in different ethnicities makes single gene testing inefficient for hearing loss. We developed a custom capture/next-generation sequencing gene panel of 146 known deafness genes with a total target size of approximately 1 MB. The genes were identified by searching databases including Hereditary Hearing Loss Homepage, the Human Genome Mutation Database (HGMD), Online Mendelian Inheritance in Man (OMIM) and most recent peer-reviewed publications related to the genetics of deafness. The design covered all coding exons, UTRs and 25 bases of intronic flanking sequences for each exon. To validate our panel, we used 6 positive controls with variants in known deafness genes and 8 unsolved samples from individuals with hearing loss. Mean coverage of the targeted exons was 697X. On average, each sample had 99.8%, 96.2% and 92.7% of the targeted region coverage of 1X, 50X and 100X reads, respectively. Analysis detected all known variants in nuclear genes. These results prove the accuracy and reliability of the custom capture experiment.

摘要

极高的基因异质性,以及不同种族中致病变异分布的显著差异,使得单基因检测对于听力损失而言效率低下。我们开发了一个包含146个已知耳聋基因的定制捕获/新一代测序基因panel,总目标大小约为1MB。这些基因是通过搜索包括遗传性听力损失主页、人类基因组突变数据库(HGMD)、《人类孟德尔遗传》(OMIM)以及与耳聋遗传学相关的最新同行评审出版物在内的数据库来确定的。该设计涵盖了每个外显子的所有编码外显子、非翻译区(UTR)以及内含子侧翼序列的25个碱基。为了验证我们的panel,我们使用了6个在已知耳聋基因中有变异的阳性对照以及8个来自听力损失个体的未解决样本。目标外显子的平均覆盖度为697倍。平均而言,每个样本在1倍、50倍和100倍读数下分别有99.8%、96.2%和92.7%的目标区域覆盖度。分析检测到了核基因中的所有已知变异。这些结果证明了定制捕获实验的准确性和可靠性。